| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1524 | 2019 |
| The genetic architecture of the human cerebral cortex KL Grasby, N Jahanshad, JN Painter, L Colodro-Conde, J Bralten, ... Science 367 (6484), eaay6690, 2020 | 569 | 2020 |
| Grey matter atrophy in cognitively impaired Parkinson's disease TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (2), 188-194, 2012 | 310 | 2012 |
| Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing Q Zhang, CL Vallerga, RM Walker, T Lin, AK Henders, GW Montgomery, ... Genome medicine 11, 1-11, 2019 | 217 | 2019 |
| Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease TR Melzer, R Watts, MR MacAskill, JF Pearson, S Rüeger, TL Pitcher, ... Brain 134 (3), 845-855, 2011 | 202 | 2011 |
| White matter microstructure deteriorates across cognitive stages in Parkinson disease TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ... Neurology 80 (20), 1841-1849, 2013 | 177 | 2013 |
| Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease CL Vallerga, F Zhang, J Fowdar, AF McRae, T Qi, MF Nabais, Q Zhang, ... Nature communications 11 (1), 1238, 2020 | 105 | 2020 |
| Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk. MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... bioRxiv 388165, 2019 | 92 | 2019 |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten npj Parkinson's Disease 5 (1), 6, 2019 | 90 | 2019 |
| Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study KL Wood, DJ Myall, L Livingston, TR Melzer, TL Pitcher, MR MacAskill, ... npj Parkinson's Disease 2 (1), 1-8, 2016 | 75 | 2016 |
| The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease MR MacAskill, CF Graham, TL Pitcher, DJ Myall, L Livingston, ... Neuropsychologia 50 (14), 3338-3347, 2012 | 72 | 2012 |
| Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease TR Melzer, MR Stark, RJ Keenan, DJ Myall, MR MacAskill, TL Pitcher, ... Frontiers in neurology 10, 391, 2019 | 64 | 2019 |
| Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI) AJ Jones, RG Kuijer, L Livingston, D Myall, K Horne, M MacAskill, ... Translational Neurodegeneration 6, 1-9, 2017 | 64 | 2017 |
| International multicenter analysis of brain structure across clinical stages of Parkinson's disease MA Laansma, JK Bright, S Al‐Bachari, TJ Anderson, T Ard, F Assogna, ... Movement disorders 36 (11), 2583-2594, 2021 | 58 | 2021 |
| Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders MF Nabais, SM Laws, T Lin, CL Vallerga, NJ Armstrong, IP Blair, JB Kwok, ... Genome biology 22, 1-30, 2021 | 50 | 2021 |
| Parkinson’s in the oldest old: Impact on estimates of future disease burden DJ Myall, TL Pitcher, JF Pearson, JC Dalrymple-Alford, TJ Anderson, ... Parkinsonism & related disorders 42, 78-84, 2017 | 46 | 2017 |
| Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease J Blommer, T Pitcher, M Mustapic, E Eren, PJ Yao, MP Vreones, ... Brain 146 (1), 195-208, 2023 | 40 | 2023 |
| Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset W Schierding, S Farrow, T Fadason, OEE Graham, TL Pitcher, S Qubisi, ... Movement Disorders 35 (8), 1346-1356, 2020 | 34 | 2020 |
| Parkinson's disease across ethnicities: a nationwide study in New Zealand TL Pitcher, DJ Myall, JF Pearson, CJ Lacey, JC Dalrymple‐Alford, ... Movement Disorders 33 (9), 1440-1448, 2018 | 33 | 2018 |
| Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort OEE Graham, TL Pitcher, Y Liau, AL Miller, JC Dalrymple-Alford, ... Parkinsonism & Related Disorders 70, 36-41, 2020 | 29 | 2020 |
j* dalrymple-alford or dalrymplealfordUniversity of CanterburyVerifisert e-postadresse på canterbury.ac.nz
